Accolade is close to announcing the acquisition of Houston-based Innovation Specialists, parent company of 2nd.MD, for about $460 million, according to people with knowledge of the situation. The transaction will be half in cash and the rest in Accolade shares, a portion of which is contingent on revenue targets, and will close next month, said the people, who declined to be identified speaking about the deal. Founded in 2011, 2nd.MD automates the process of getting second opinions so they happen within days over video or telephone, rather than taking weeks to schedule as is more typical.
Pamela Smith, 72, a former Guilford resident and previous head of a Connecticut staffing agency, pleaded guilty on a federal tax charge, the U.S. Attorney announced Wednesday. She faces three years in prison.
Tower Health has hired a restructuring advisor and plans to sell its Philadelphia-area hospitals after posting large losses in 2019 and 2020. The struggling Tower Health chief financial officer is resigning, the Pennsylvania health system said on Wednesday.
Following last week’s riot here, several major health care corporations are reevaluating their support for the 147 Republican lawmakers who voted against certifying the results of November’s presidential election.